Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Dr Lalchandani Labs IPO is a fixed price issue of ₹4.20 crores. The issue is entirely a fresh issue of 0.14 crore shares of ₹4.20 crore.
Dr Lalchandani Labs IPO bidding started from Apr 25, 2018 and ended on Apr 27, 2018. The shares got listed on BSE SME on May 9, 2018.
Dr Lalchandani Labs IPO price is ₹30.00 per share . The lot size for an application is 4,000. The minimum amount of investment required by an individual investor (retail) is ₹1,20,000 (4000 shares). The minimum lot size investment for HNI is 2 lots (8,000 shares), amounting to ₹2,40,000.
Navigant Corporate Advisors Ltd. is the book running lead manager and Cameo Corporate Services Ltd. is the registrar of the issue. The market maker of the company is NNM Securities Pvt.Ltd..
Refer to Dr Lalchandani Labs IPO RHP for detailed Information.
| IPO Date | April 25, 2018 to April 27, 2018 |
| Listing Date | May 9, 2018 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹30 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 14,00,000 shares (aggregating up to ₹4.20 Cr) |
| Reserved for Market Maker | 72,000 shares NNM Securities Pvt.Ltd. (aggregating up to ₹0.2160 Cr) |
| Net Offered to Public | 13,28,000 shares (aggregating up to ₹3.98 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 29,33,068 shares |
| Share Holding Post Issue | 43,33,068 shares |
Dr Lalchandani Labs IPO offers total 14,00,000 shares. Out of which 6,64,000 (47.43%) allocated to NII, 6,64,000 (47.43%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 72,000 (5.14%) |
| NII (HNI) Shares Offered | 6,64,000 (47.43%) |
| Retail Shares Offered | 6,64,000 (47.43%) |
| Total Shares Offered | 14,00,000 (100.00%) |
Dr Lalchandani Labs IPO opens on April 25, 2018, and closes on April 27, 2018.
| IPO Open Date | Wed, Apr 25, 2018 |
| IPO Close Date | Fri, Apr 27, 2018 |
| Tentative Listing Date | Wed, May 9, 2018 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Apr 27, 2018 |
Investors can bid for a minimum of 4,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹1,20,000 |
| Retail (Max) | 1 | 4,000 | ₹1,20,000 |
| HNI (Min) | 2 | 8,000 | ₹2,40,000 |
Incorporated in 2011, Delhi based Dr. Lalchandani Labs Limited is a provider of diagnostic and related healthcare tests. Through its integrated network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
The Company is NABL Accredited Lab and has established 5 (Five) Self-Sufficient Labs and multiple collection centers within Delhi/NCR.
The Company is managing/servicing labs at some of the leading hospitals and operating retail outlets such as-
o Primus Super Specialty Hospital, Chanakyapuri
o Nanda Hospital, Chattarpur (70 Bedded)
o Eden Hospital, East of Kailash (25 Bedded)
o East of Kailash Retail outlet
o Dr Raturi Hospital, Khatima, Uttrakhand
o Lords Day care Centre, Bhogal New Delhi
o Greater Kailash Part 1 - Retail outlet & Head office
o Lajpat Nagar 2 - Retail Flagship outlet
o Shahdra - Retail outlet
o Dwarka Sector 19 - Retail outlet
Arya Samaj Mandir Sarojini Nagar- Charitable Retail Outlet
o Arya Samaj Mandir Malviya Nagar - Charitable Retail Outlet
o Arya Samaj Mandir Kalkaji - Charitable Retail outlet
o Arya Samaj Mandir Kasturbha Nagar - Charitable Retail Outlet
o Jampur Bhawan - Charitable Retail outlet
o Laxmi Narayan Mandir Malviya Nagar - Charitable Retail Outlet
The Company has a Blood Banking services through its sister concern CPC blood bank founded by Dr. A Lalchandani himself in 1987.
| Particulars | For the year/period ended (in Rs. Lacs) | |||||
|---|---|---|---|---|---|---|
| 31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
| Total Assets | 376.39 | 366.45 | 187.16 | 168.93 | 165.22 | |
| Total Revenue | 461.67 | 302.81 | 192.79 | 141.39 | 121.96 | |
| Profit After Tax | 70.74 | 32.32 | 31.91 | 4.13 | 1.93 | |
The Company Dr Lalchandani Labs IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | To open second major processing center (2000 sq. ft. area) in Delhi/NCR. | 0.35 |
| 2 | Repayment/pre-payment, in full or part, of certain borrowings availed by the Company | 1.00 |
| 3 | To purchase advanced machinery and equipment | 0.50 |
| 4 | To open new collection centers based on COCO model | 0.27 |
| 5 | To Develop E- Applications and E Programs and other I.T. support system. | 0.11 |
| 6 | For Recruitment, Training and Placement of staff to expand operations and other operational expenses | 0.62 |
| 7 | For general corporate purposes | 1.00 |
[Dilip Davda] <p>Analytical testing labs segment is doing better and set for bright prospects ahead. Investors may consider investment in this reasonably priced offer for long term.</p> Read detail review...
| Listing Date | May 9, 2018 |
| BSE Script Code | 541299 |
| NSE Symbol | |
| ISIN | INE871Z01013 |
| Final Issue Price | ₹30 per share |
| BSE Listing Group | MT |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹30.00 |
| Open | ₹29.95 |
| Low | ₹28.50 |
| High | ₹29.95 |
| Last Trade | ₹28.50 |
Dr Lalchandani Labs Ltd.
M-20,
Basement,
Greater Kailash-1
New Delhi, New Delhi, 110048
Phone: 011 49057058
Email: info@lalchandanipathlab.com
Website: http://www.lalchandanipathlab.com/
Cameo Corporate Services Ltd.
Phone: +91-44-28460390
Email: cameo@cameoindia.com
Website: https://ipo.cameoindia.com/
Dr Lalchandani Labs IPO is a SME IPO of 14,00,000 equity shares of the face value of ₹10 aggregating up to ₹4.20 Crores. The issue is priced at ₹30 per share. The minimum order quantity is 4000.
The IPO opens on April 25, 2018, and closes on April 27, 2018.
Cameo Corporate Services Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Dr Lalchandani Labs IPO using UPI as a payment gateway. Zerodha customers can apply in Dr Lalchandani Labs IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Dr Lalchandani Labs IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Dr Lalchandani Labs IPO opens on April 25, 2018 and closes on April 27, 2018.
Dr Lalchandani Labs IPO lot size is 4000, and the minimum amount required for application is ₹1,20,000.
You can apply in Dr Lalchandani Labs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Dr Lalchandani Labs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Dr Lalchandani Labs IPO allotment status.
The Dr Lalchandani Labs IPO listing date is on Wednesday, May 9, 2018.
Useful Articles
RHP